Skip to main content

Division of Cardiovascular Medicine Archives

Peptides promote AFib arrhythmia

Apr. 11, 2022—Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.

Read more


Department of Medicine announces $1 million endowment to support diversity, inclusion efforts

Mar. 14, 2022—Vanderbilt University Medical Center’s Department of Medicine has announced a $1 million endowment dedicated to the department’s efforts in diversity and inclusion.

Read more


American College of Cardiology honors Vanderbilt’s Dixon, Thomas

Mar. 10, 2022—Two fellows in Vanderbilt's Division of Cardiovascular Medicine have received awards from the American College of Cardiology and the Association of Black Cardiologists.

Read more


Chest Pain Center receives reaccreditation from ACC

Mar. 3, 2022—Vanderbilt University Medical Center has been reaccredited as a Chest Pain Center with Primary Percutaneous Coronary Intervention (PCI) and Resuscitation.

Read more


Study finds genetic testing useful for young AFib patients

Oct. 7, 2021—Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.

Read more


Stevenson receives HFSA Lifetime Achievement Award

Sep. 23, 2021—Vanderbilt's Lynne Warner Stevenson, MD, has received  the Lifetime Achievement Award from the Heart Failure Society of America.

Read more


New Clinician Spotlight: Jane Freedman

Sep. 8, 2021—Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute.

Read more


Regulators of fat cell metabolism

Sep. 7, 2021—Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.

Read more


Potential protection from atherosclerosis

Aug. 19, 2021—Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins.

Read more


COVID-19 complication underdiagnosed

Jun. 17, 2021—A mysterious inflammatory syndrome linked to COVID-19 infection and first identified in children also occurs in adults, Vanderbilt researchers report.

Read more


New Clinician Spotlight: Andrew DeFilippis

Jun. 1, 2021—Andrew DeFilippis, MD, has joined Vanderbilt University Medical Center from the University of Louisville School of Medicine. He began seeing patients in September 2020.

Read more


Residents, fellows step up to help care for COVID patients

Jan. 14, 2021—Following a Thanksgiving surge that led to record numbers of admissions of patients with COVID-19, residents and fellows from multiple disciplines have come together under the direction and supervision of critical care attendings to provide the best care to critically ill patients in Vanderbilt University Medical Center’s COVID-19 Intensive Care Unit.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more